![Charles Michael Markbreiter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Michael Markbreiter
Plus aucun poste en cours
Profil
Mr. Charles M.
Markbreiter is Independent Director at Impax Laboratories, Inc. and a Director at Alyn Corp.
He is on the Board of Directors at Impax Laboratories, Inc. and Alyn Corp.
Mr. Markbreiter was previously employed as a Portfolio Manager by Sofaer Capital, Inc. and a Portfolio Manager by Kingdon Capital Management LLC.
He received his undergraduate degree from the University of Cambridge.
Anciens postes connus de Charles Michael Markbreiter
| Sociétés | Poste | Fin |
|---|---|---|
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Directeur/Membre du Conseil | 17/05/2016 |
Sofaer Capital, Inc.
 Sofaer Capital, Inc. Financial ConglomeratesFinance Alternative investment manager | Corporate Officer/Principal | 01/09/2001 |
Kingdon Capital Management LLC
 Kingdon Capital Management LLC Investment ManagersFinance Kingdon aims to achieve attractive risk-adjusted returns across all market cycles. The firm adheres to research driven process, investing across geographies, industries and asset classes to find the best use of capital. They offer two investment strategies: a global long/short equity strategy (Flagship Strategy) and a global long/short healthcare strategy (Healthcare Strategy). The Flagship Strategy consists of thematic, idiosyncratic and opportunistic investments with diversified return drivers and an emphasis on liquidity. The Healthcare Strategy primarily invests in the global healthcare industry. | Corporate Officer/Principal | 01/12/1998 |
Alyn Corp.
 Alyn Corp. Metal FabricationProducer Manufacturing Provides engineered metal matrix composite solutions | Directeur/Membre du Conseil | - |
Formation de Charles Michael Markbreiter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Kingdon Capital Management LLC
Kingdon Capital Management LLC Investment ManagersFinance Kingdon aims to achieve attractive risk-adjusted returns across all market cycles. The firm adheres to research driven process, investing across geographies, industries and asset classes to find the best use of capital. They offer two investment strategies: a global long/short equity strategy (Flagship Strategy) and a global long/short healthcare strategy (Healthcare Strategy). The Flagship Strategy consists of thematic, idiosyncratic and opportunistic investments with diversified return drivers and an emphasis on liquidity. The Healthcare Strategy primarily invests in the global healthcare industry. | Finance |
Alyn Corp.
Alyn Corp. Metal FabricationProducer Manufacturing Provides engineered metal matrix composite solutions | Producer Manufacturing |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Health Technology |
Sofaer Capital, Inc.
Sofaer Capital, Inc. Financial ConglomeratesFinance Alternative investment manager | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
